Publications (26) Publications in which a researcher has participated

2023

  1. Drastic decline in vasoactive intestinal peptide expression in the suprachiasmatic nucleus in obese mice on a long-term high-fat diet

    Brain Research Bulletin, Vol. 202

  2. Expression of RAD9B in the mesostriatal system of rats and humans: Overexpression in a 6-OHDA rat model of Parkinson's disease

    Annals of Anatomy, Vol. 250

  3. Morphological study of neuropeptide Y expression in human and mouse anterior insular cortex: Overexpression in the insular cortex and nucleus accumbens in obese mice on a long-term obesogenic diet

    Annals of Anatomy, Vol. 250

2022

  1. Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease

    Molecular and Cellular Neuroscience, Vol. 118

2021

  1. Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism

    Pharmacological Research, Vol. 165

2020

  1. DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis

    Autophagy, Vol. 16, Núm. 7, pp. 1279-1295

2019

  1. Uso Terapéutico de los Cannabinoides en la Enfermedad De Parkinson. Revisión

    Majorensis: Revista Electrónica de Ciencia y Tecnología, Núm. 15, pp. 1-8

2018

  1. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease

    Experimental Neurology, Vol. 299, pp. 137-147

2016

  1. A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses

    Molecular Therapy - Methods and Clinical Development, Vol. 3, pp. 16027

  2. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system

    Neurobiology of Disease, Vol. 88, pp. 44-54

2015

  1. D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly

    Neurobiology of Disease, Vol. 78, pp. 77-87

  2. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake

    Neurobiology of Disease, Vol. 74, pp. 325-335

2014

  1. Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons

    Frontiers in Neuroanatomy, Vol. 8, Núm. AUG

2012

  1. Differential N termini in epithelial Na + channel δ-subunit isoforms modulate channel trafficking to the membrane

    American Journal of Physiology - Cell Physiology, Vol. 302, Núm. 6

2010

  1. The dopamine transporter is differentially regulated after dopaminergic lesion

    Neurobiology of Disease, Vol. 40, Núm. 3, pp. 518-530

  2. The neuronal-specific SGK1.1 kinase regulates δ-epithelial Na + channel independently of PY motifs and couples it to phospholipase C signaling

    American Journal of Physiology - Cell Physiology, Vol. 299, Núm. 4

  3. Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease

    Frontiers in Neuroanatomy

2009

  1. Aging effects on the dopamine transporter expression and compensatory mechanisms

    Neurobiology of Aging, Vol. 30, Núm. 6, pp. 973-986

  2. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease

    Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508

  3. Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons

    Journal of Neural Transmission, Supplementa, pp. 21-37